IMP Manufacture, Labelling and Packaging DPS
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £15,000,000 |
|---|---|
| Status | active |
| Category (CPV) | 33600000 +6 more |
| Deadline | 22 Aug 2034 |
| Procedure | selective |
| OCID | ocds-h6vhtk-0493d1 |
description
The London School of Hygiene and Tropical Medicine (LSHTM) is implementing a Dynamic Purchasing System (DPS) for the procurement of services related to the provision of investigational medicinal products (IMPs) for clinical trials. The DPS is intended to be a long term, 10 year, system to support the work of the CTU for both large and small trials.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 23 Aug 2024 | Contract notice (F02) | Earlier regulations | 027163-2024 |
more from London School of Hygiene & Tropical Medicine
- Insurance Service · 3 Jun 2025
- In Vivo Imaging System - Maintenance · 20 Feb 2025
- Asbestos - Management & Testing · £150,000 · 15 Nov 2024
- Student Case Management Solution · £70,000 · 11 Nov 2024
- Occupational Health Service · 10 Oct 2024
- Research Grants Management System · 9 Oct 2024
- Service and Maintenance of Safety and Fume Cabinets · £125,000 · 8 Aug 2024
- Virtual Platform · £75,000 · 17 Jul 2024
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.